Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy

S. P. Chawla; S. Pollack; M. Block; M. Druta; K. Do; J. C. Morris; J. W. Kim; C. Bohac; H. Lu; S. Gnjatic; R. L. Jones; P. Hwu; N. Somaiah

doi:10.1093/annonc/mdy299.006

Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy

S. P. Chawla, S. Pollack, M. Block, M. Druta, K. Do, J. C. Morris, J. W. Kim, C. Bohac, H. Lu, S. Gnjatic, R. L. Jones, P. Hwu, N. Somaiah

Medical Oncology

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	viii578
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy299.006
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy299.006

Cite this

Chawla, S. P., Pollack, S., Block, M., Druta, M., Do, K., Morris, J. C., Kim, J. W., Bohac, C., Lu, H., Gnjatic, S., Jones, R. L., Hwu, P., & Somaiah, N. (2018). Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii578. https://doi.org/10.1093/annonc/mdy299.006

Chawla, SP, Pollack, S, Block, M, Druta, M, Do, K, Morris, JC, Kim, JW, Bohac, C, Lu, H, Gnjatic, S, Jones, RL, Hwu, P & Somaiah, N 2018, 'Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii578. https://doi.org/10.1093/annonc/mdy299.006

@article{28779c2066df4391bbfc4b101feffc4b,

title = "Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy",

author = "Chawla, {S. P.} and S. Pollack and M. Block and M. Druta and K. Do and Morris, {J. C.} and Kim, {J. W.} and C. Bohac and H. Lu and S. Gnjatic and Jones, {R. L.} and P. Hwu and N. Somaiah",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy299.006",

language = "English (US)",

volume = "29",

pages = "viii578",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy

AU - Chawla, S. P.

AU - Pollack, S.

AU - Block, M.

AU - Druta, M.

AU - Do, K.

AU - Morris, J. C.

AU - Kim, J. W.

AU - Bohac, C.

AU - Lu, H.

AU - Gnjatic, S.

AU - Jones, R. L.

AU - Hwu, P.

AU - Somaiah, N.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081081251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081081251&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy299.006

DO - 10.1093/annonc/mdy299.006

M3 - Article

C2 - 32137529

SN - 0923-7534

VL - 29

SP - viii578

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this